Evaluation of Different Diagnostic Methods of Tuberculosis in Assiut University Hospitals
Launched by ASSIUT UNIVERSITY · Oct 29, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on finding the best ways to diagnose tuberculosis (TB), a serious infection that affects the lungs. Researchers will compare different diagnostic methods, including a microscope test and a modern DNA test called PCR, against the traditional culture method, which is considered the most reliable. The goal is to determine which method is the most accurate for diagnosing TB, especially in patients who show symptoms of the disease.
To participate in this study, individuals must either have symptoms that suggest they might have TB or have already been diagnosed with it. However, people with other types of lung infections that are not TB will not be included. Since the trial is not yet recruiting participants, it is still in the planning stages. Those who take part can expect to help improve TB diagnosis, which could lead to better treatment and care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with signs and symptoms of tuberculosis (suspected cases)
- • Patients diagnosed with tuberculosis.
- Exclusion Criteria:
- • Patients with pulmonary infections other than TB
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported